miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p

References

• Zeisig BB, Kulasekararaj AG, Mufti GJ, et al. SnapShot: acute myeloid leukemia. Cancer Cell. 2012;22:698–698 e691.
   PubMedGoogle Scholar
• Wang XS, Gong JN, Yu J, et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood. 2012;119:4992–5004.
   PubMed Web of Science ®Google Scholar
• Deng L, Jiang L, Lin XH, et al. The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia. Acta Pharmacol Sin. 2017;38:382–391.
   PubMed Web of Science ®Google Scholar
• Schoof EM, Lechman ER, Dick JE. Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia. Data Brief. 2016;9:57–61.
   PubMed Web of Science ®Google Scholar
• Lu F, Zhang J, Ji M, et al. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int J Oncol. 2014;45:383–392.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Hu Y, Dong X, Chu G, et al. miR-137 downregulates c-kit expression in acute myeloid leukemia. Leuk Res. 2017;57:72–77.
   PubMed Web of Science ®Google Scholar
• Krowiorz K, Ruschmann J, Lai C, et al. MiR-139-5p is a potent tumour suppressor in adult acute myeloid leukemia. Blood Cancer J. 2016;6:e508.
   PubMed Web of Science ®Google Scholar
• Zhang TJ, Wang YX, Yang DQ, et al. Down-regulation of miR-186 correlates with poor survival in de novo acute myeloid leukemia. Clin Lab. 2016;62:113–120.
   PubMed Web of Science ®Google Scholar
• Si X, Zhang X, Hao X, et al. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion. Oncotarget. 2016;7:78095–78109.
   PubMedGoogle Scholar
• Gao Y, Zhang SG, Wang ZH, et al. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance. Euro Rev Med Pharmacol Sci. 2017;21:2098–2102.
   PubMed Web of Science ®Google Scholar
• Li XR, Chu HJ, Lv T, et al. miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. FEBS Lett. 2014;588:3298–3307.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang Y. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-kappaB pathway. Biochem Biophys Res Commun. 2015;457:370–377.
   PubMed Web of Science ®Google Scholar
• Tai MC, Kajino T, Nakatochi M. et al. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis. 2015;36:1464–1473.
   PubMed Web of Science ®Google Scholar
• Lim JH, Park JW, Chun YS. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res. 2006;66:10677–10682.
   PubMed Web of Science ®Google Scholar
• Seo JH, Cha JH, Park JH, et al. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res. 2010;70:4422–4432.
   PubMed Web of Science ®Google Scholar
• Arnesen T, Gromyko D, Pendino F, et al. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene. 2006;25:4350–4360.
   PubMed Web of Science ®Google Scholar
• Lee MN, Lee SN, Kim SH, et al. Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumour growth and metastasis. J Nat Cancer Inst. 2010;102:426–442.
   PubMedGoogle Scholar
• Ohkawa N, Sugisaki S, Tokunaga E, et al. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes to Cells: Devoted to Mol Cell Mech. 2008;13:1171–1183.
   PubMed Web of Science ®Google Scholar
• Kuo HP, Lee DF, Chen CT, et al. ARD1 stabilization of TSC2 suppresses tumourigenesis through the mTOR signaling pathway. Sci Signal. 2010;3:ra9.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zheng J, Zhao J, et al. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma. Tumour Biol. 2016;37:6719–6728.
   PubMedGoogle Scholar
• Arnesen T, Thompson PR, Varhaug JE, et al. The protein acetyltransferase ARD1: a novel cancer drug target? Curr Cancer Drug Targ. 2008;8:545–553.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Min L, Han Y, et al. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis. Carcinogenesis. 2014;35:2244–2253.
   PubMed Web of Science ®Google Scholar
• Xie X, Liu H, Wang M, et al. miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumour Biol. 2015;36:5031–5038.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu L, Lv Z, et al. MicroRNA-342-3p inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting astrocyte-elevated gene-1 (AEG-1). Oncol Res. 2017;09:1505–1515.
   Web of Science ®Google Scholar
• Huang H, Fan L, Zhan R, et al. Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type. Oncol Lett. 2016;11:345–351.
   PubMed Web of Science ®Google Scholar
• Crippa E, Lusa L, De Cecco L, et al. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer. PloS One. 2014;9:e87039.
   PubMed Web of Science ®Google Scholar
• Weng C, Nguyen T, Shively JE. miRNA-342 Regulates CEACAM1-induced lumen formation in a three-dimensional model of mammary gland morphogenesis. J Biol Chem. 2016;291:16777–16786.
   PubMed Web of Science ®Google Scholar
• Smid D, Kulda V, Srbecka K, et al. Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy. Int J Oncol. 2016;48:2693–2703.
   PubMed Web of Science ®Google Scholar